You have 9 free searches left this month | for more free features.

Breast Carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

Recruiting
  • Pleomorphic Lobular Breast Carcinoma in Situ
  • Breast Florid Lobular Carcinoma in Situ
  • Surgical wide local excision
  • +4 more
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Nov 14, 2023

Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)

Not yet recruiting
  • Lobular Breast Carcinoma
  • 68Ga-FAPI-46 PET scan
  • Monaco, Monaco
    Centre Hospitalier Princesse Grace
Jun 27, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma Trial (other, procedure, behavioral)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Electronic Health Record Review
  • +6 more
  • (no location specified)
Oct 27, 2023

Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Control Arm ACSM Guidelines
  • Experimental Arm 6-12-25 repetitions per set
  • (no location specified)
Nov 6, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma

Not yet recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +3 more
  • Accelerated Partial Breast Irradiation
  • Duarte, California
    City of Hope Medical Center
Aug 18, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +5 more
  • Intraoperative Imaging
  • Lumpectomy
  • Chicago, Illinois
  • +3 more
Nov 30, 2022

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lobular Breast Carcinoma
  • Blood Specimen
  • San Francisco, California
    University of California, San Francisco
Jul 19, 2023

Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

Recruiting
  • Breast Cancer
  • +4 more
  • 18F-FDG PET/CT
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 17, 2023

Standard Breast Cancer Risk Assessment for African American and

Not yet recruiting
  • Breast Atypical Ductal Hyperplasia
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Feb 22, 2023

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Pre-analytical Factors Affecting ctDNA Analysis in Early and

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jul 6, 2023

Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

Active, not recruiting
  • Breast Cancer
  • +4 more
  • External Beam Radiation Therapy
  • +2 more
  • Richmond, Virginia
  • +1 more
Dec 16, 2022

Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +4 more
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 24, 2023

Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Triple Negative Breast Cancer
  • +6 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
  • +1 more
Mar 8, 2023

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

SCOUT® Radar Localization in Nonpalpable Breast Lesions

Recruiting
  • Breast Cancer
  • Occult Breast Carcinoma
  • SCOUT® Radar occult breast lesion Localization
  • Milan, Italy
    European Institute of Oncology
Jul 27, 2023

Patients Undergoing Breast Biopsy

Recruiting
  • Breast Carcinoma
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 27, 2023

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Breast Cancer, Ductal Carcinoma, Invasive Breast Carcinoma Trial in Tampa (Talimogene laherparepvec, Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Cultural Acceptability of Community Breast Cancer Risk

Recruiting
  • Breast Carcinoma
  • +2 more
  • Non-Interventional Study
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Oct 31, 2023

Metastatic HER2-Negative Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in Nashville (Biospecimen

Not yet recruiting
  • Metastatic HER2-Negative Breast Carcinoma
  • Metastatic Triple-Negative Breast Carcinoma
  • Biospecimen Collection
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Mar 3, 2023